New Releases from NCBI BookshelfDabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma.​Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma.

Post Content

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top